The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase 2 clinical trial of ixabepilone in metastatic cervical carcinoma.
Mauricio Emmanuel Burotto Pichun
No relevant relationships to disclose
Sanjeeve Bala
No relevant relationships to disclose
Maureen Edgerly
No relevant relationships to disclose
Julia Wilkerson
No relevant relationships to disclose
Margarita Velarde
No relevant relationships to disclose
Herbert L. Kotz
No relevant relationships to disclose
Susan Elaine Bates
No relevant relationships to disclose
Antonio Tito Fojo
No relevant relationships to disclose